185 related articles for article (PubMed ID: 17432718)
21. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
22. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
23. Reduced glioma infiltration in Src-deficient mice.
Lund CV; Nguyen MT; Owens GC; Pakchoian AJ; Shaterian A; Kruse CA; Eliceiri BP
J Neurooncol; 2006 May; 78(1):19-29. PubMed ID: 16552622
[TBL] [Abstract][Full Text] [Related]
24. Brain tumors in S100beta-v-erbB transgenic rats.
Ohgaki H; Kita D; Favereaux A; Huang H; Homma T; Dessen P; Weiss WA; Kleihues P; Heppner FL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1111-7. PubMed ID: 17146284
[TBL] [Abstract][Full Text] [Related]
25. A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC
Toxicol Pathol; 2000; 28(1):171-7. PubMed ID: 10669005
[TBL] [Abstract][Full Text] [Related]
26. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
[TBL] [Abstract][Full Text] [Related]
27. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.
Learn CA; Grossi PM; Schmittling RJ; Xie W; Mitchell DA; Karikari I; Wei Z; Dressman H; Sampson JH
J Neuroimmunol; 2007 Jan; 182(1-2):63-72. PubMed ID: 17137636
[TBL] [Abstract][Full Text] [Related]
29. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
30. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
[TBL] [Abstract][Full Text] [Related]
31. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
[TBL] [Abstract][Full Text] [Related]
32. A syngeneic mouse glioma model for study of glioblastoma therapy.
Weiner NE; Pyles RB; Chalk CL; Balko MG; Miller MA; Dyer CA; Warnick RE; Parysek LM
J Neuropathol Exp Neurol; 1999 Jan; 58(1):54-60. PubMed ID: 10068314
[TBL] [Abstract][Full Text] [Related]
33. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
[TBL] [Abstract][Full Text] [Related]
34. Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation.
Valadez JG; Sarangi A; Lundberg CJ; Cooper MK
J Vis Exp; 2014 Jan; (83):e50865. PubMed ID: 24458098
[TBL] [Abstract][Full Text] [Related]
35. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
[TBL] [Abstract][Full Text] [Related]
36. Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
Horst Mt; Brouwer E; Verwijnen S; Rodijk M; de Jong M; Hoeben R; de Leeuw B; Smitt PS
J Gene Med; 2007 Dec; 9(12):1071-9. PubMed ID: 17902184
[TBL] [Abstract][Full Text] [Related]
37. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells.
Adach-Kilon A; Swiatek-Machado K; Kaminska B; Dabrowski M
J Cell Biochem; 2011 Dec; 112(12):3685-94. PubMed ID: 21815198
[TBL] [Abstract][Full Text] [Related]
38. Inoculation of C6 cell suspension into the brain of adult rats: immunohistochemical study.
Mokrý J; Nĕmecek S; Adler J; Dĕdic K
Funct Dev Morphol; 1993; 3(3):175-80. PubMed ID: 8167397
[TBL] [Abstract][Full Text] [Related]
39. Applications of mouse glioma models in preclinical trials.
Hu X; Holland EC
Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
[TBL] [Abstract][Full Text] [Related]
40. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.
Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y
Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
